學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Living with the Virus: Singapore's 2021 Endemic Strategy in the COVID-19 Pandemic
內容大綱
On September 24, 2021, the Singapore Multi-Ministry Task Force (MTF) that spearheaded the national COVID-19 pandemic response decided to act more decisively to ensure that its endemic strategy would not be derailed by the infections which had been escalating since late August. In the weeks that followed, the MTF tightened measures on social interaction, encouraged work-from-home as the default mode of working and simplified its testing and isolation protocols. The third vaccination (booster shot) programme was also quickly rolled out. The public had become discontented due to the rising infections and deaths of the elderly, as well as the ever-changing restrictions, protocols, and proclaimed phases that had been introduced since April 2021. There also existed an issue of perceived discrimination that arose from the segmented access according to vaccination status. As a public health analyst, David Chong had been assessing Singapore's COVID-19 endemic strategy - to ascertain the areas that Singapore had done well, as well as those they could do better. How should Chong advise other countries to plan an endemic strategy?